Fri, Dec 26, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

PING Capital reaps returns from volatile emerging markets

Wednesday, October 02, 2013

Beverly Chandler, Opalesque London:

PING Capital Management has enjoyed good returns for its Exceptional Value Fund, up an estimated 24.58% year to date, 447.47% since inception in 2008 and the Emerging Market Macro Fund which is up 6.8% year to date, 32.04% since inception in 2010. PINg Capital was founded in February 2008, by Ping Jiang and began with an investment team from SAC Capital. The firm has trading operations in New York and Shanghai.

The PING Exceptional Value Fund LP (onshore feeder) focuses on global macro strategies with an emphasis on China, Latin America, and other emerging markets opportunities. PING Capital invests in a focused strategy of core investment themes with relatively low leverage, developed from economic fundamental research and valuation anomalies in emerging markets. The firm explains that while they mainly use a directional strategy, the Fund also seeks to profit from relative value and short term trading opportunities. Instruments traded include local and external bonds, currencies, equities, commodities, and derivatives. PING Capital’s team has had extensive experience in derivative trading and analysis and uses a research driven and quantitative oriented trading approach.

PING writes: "The Fund’s internal macroeconomic research provides ideas about the valuations and economic risk in the markets; however the investment team does not make the investment decisions based sol......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its